Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide

Biomarker‐guided dosing may improve the efficacy and toxicity of cyclophosphamide (CY); however, clinical studies evaluating their association with the area under the plasma concentration–time curve (AUC) of CY and its metabolites are time‐ and resource‐intensive. Therefore, we sought to identify li...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro, Sandi L., Zheng, Zihan, Randolph, Timothy W., Nakamura, Ryotaro, Sandmaier, Brenda M., Hockenbery, David, McCune, Jeannine S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652445/
https://www.ncbi.nlm.nih.gov/pubmed/36088654
http://dx.doi.org/10.1111/cts.13404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652445/
https://www.ncbi.nlm.nih.gov/pubmed/36088654
http://dx.doi.org/10.1111/cts.13404

Ejemplares similares